ArticleArchives of gynecology and obstetrics2026
Characterization of exceptional responders with long-term PARP inhibitor therapy in recurrent ovarian cancer: an analysis of 23 patients from Charité.
Jacek Glajzer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.